Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

373 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group Study.
Veal GJ, Cole M, Errington J, Parry A, Hale J, Pearson AD, Howe K, Chisholm JC, Beane C, Brennan B, Waters F, Glaser A, Hemsworth S, McDowell H, Wright Y, Pritchard-Jones K, Pinkerton R, Jenner G, Nicholson J, Elsworth AM, Boddy AV; Kingdom Children's Cancer Study Group Pharmacology Working Group. Veal GJ, et al. Among authors: errington j. Clin Cancer Res. 2005 Aug 15;11(16):5893-9. doi: 10.1158/1078-0432.CCR-04-2546. Clin Cancer Res. 2005. PMID: 16115931 Clinical Trial.
Biliary excretion of etoposide in children with cancer.
Veal GJ, Errington J, Thomas HD, Boddy AV, Lowis S. Veal GJ, et al. Among authors: errington j. Cancer Chemother Pharmacol. 2006 Sep;58(3):415-7. doi: 10.1007/s00280-005-0180-7. Epub 2006 Jan 18. Cancer Chemother Pharmacol. 2006. PMID: 16418874
Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma - a study of the United Kingdom Children's Cancer Study Group.
Veal GJ, Cole M, Errington J, Pearson AD, Foot AB, Whyman G, Boddy AV; UKCCSG Pharmacology Working Group. Veal GJ, et al. Among authors: errington j. Br J Cancer. 2007 Feb 12;96(3):424-31. doi: 10.1038/sj.bjc.6603554. Epub 2007 Jan 16. Br J Cancer. 2007. PMID: 17224928 Free PMC article.
Adaptive dosing and platinum-DNA adduct formation in children receiving high-dose carboplatin for the treatment of solid tumours.
Veal GJ, Errington J, Tilby MJ, Pearson AD, Foot AB, McDowell H, Ellershaw C, Pizer B, Nowell GM, Pearson DG, Boddy AV; UKCCSG Pharmacology Working Group. Veal GJ, et al. Among authors: errington j. Br J Cancer. 2007 Mar 12;96(5):725-31. doi: 10.1038/sj.bjc.6603607. Epub 2007 Feb 13. Br J Cancer. 2007. PMID: 17299395 Free PMC article.
Dosing of cancer patients with low or absent renal function.
Boddy A, Griffin M, Knowles S, Persic M, Scott I, Errington J, Veal G. Boddy A, et al. Among authors: errington j. Therapie. 2007 Mar-Apr;62(2):117-20. doi: 10.2515/therapie:2007022. Epub 2007 Jun 21. Therapie. 2007. PMID: 17582312 No abstract available.
Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patients.
Veal GJ, Cole M, Errington J, Pearson AD, Gerrard M, Whyman G, Ellershaw C, Boddy AV. Veal GJ, et al. Among authors: errington j. Cancer Chemother Pharmacol. 2010 May;65(6):1057-66. doi: 10.1007/s00280-009-1111-9. Epub 2009 Aug 23. Cancer Chemother Pharmacol. 2010. PMID: 19701749 Clinical Trial.
373 results